Showing results (251-260 of 639) with videos related to

Sort By:
Pageof 64
Cancer Treatment Reviews|July 4, 2024
Circulating tumor DNA to guide diagnosis and treatment of localized and locally advanced non-small cell lung cancerArianna Marinello, Marco Tagliamento, Arianna Pagliaro, et al.
Oral Oncology|July 27, 2019
Lack of efficacy of neoadjuvant chemotherapy in adult patients with maxillo-facial high-grade osteosarcomas: A French experience in two reference centersJebrane Bouaoud, Guillaume Beinse, Nicolas Epaillard, et al.
Autoimmunity Reviews|June 15, 2020
Immune checkpoint inhibitor-induced myositis, the earliest and most lethal complication among rheumatic and musculoskeletal toxicitiesYves Allenbach, Céline Anquetil, Ali Manouchehri, et al.
European Journal of Cancer (Oxford, England : 1990)|July 26, 2017
RECIST response and variation of circulating tumour cells in phase 1 trials: A prospective multicentric studyChristophe Massard, Isabelle Borget, Françoise Farace, et al.
Acta Oncologica (Stockholm, Sweden)|June 5, 2023
FOLFIRI in advanced platinum-resistant/refractory small-cell lung cancer: a retrospective studyCyril Roussel-Simonin, Paul Gougis, Donia Lassoued, et al.
European Journal of Cancer (Oxford, England : 1990)|January 2, 2023
Immune checkpoint blockers in patients with unresectable or metastatic thymic epithelial tumours: A meta-analysisJordi Remon, Guillermo Villacampa, Francesco Facchinetti, et al.
Plos One|October 11, 2018
Neutrophilia as prognostic biomarker in locally advanced stage III lung cancerAntoine Schernberg, Laura Mezquita, Angela Boros, et al.
The Journal of Infectious Diseases|April 14, 2020
New Kaposi's sarcoma-associated herpesvirus variant in men who have sex with men associated with severe pathologiesAude Jary, Valentin Leducq, Nathalie Desire, et al.
American Journal of Ophthalmology Case Reports|February 9, 2026
Bilateral myelin oligodendrocyte glycoprotein antibody-associated disease after cataract surgeryBenjamin Besse, Amélie Dos Santos, Mathieu Mille, et al.
Targeted Oncology|May 7, 2009
QT interval prolongation among patients treated with angiogenesis inhibitorsStephane Ederhy, Ariel Cohen, Ghislaine Dufaitre, et al.
Pageof 64